2025-12-28 - Analysis Report
Okay, let's break down this analysis of Intuitive Surgical (ISRG).

**Company Overview:** Intuitive Surgical designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1) Return Rate Comparison**

*   **ISRG Cumulative Return:** 113.53%
*   **VOO (S&P 500) Cumulative Return:** 103.21%
*   **Divergence:** 10.73 (Current difference in cumulative return)
*   **Relative Divergence:** 35.5 (Indicates the divergence is at the 35.5th percentile of its historical range).

**Analysis:**

*   ISRG has outperformed the S&P 500 over the specified period, resulting in a cumulative return difference of approximately 10.73%.
*   The relative divergence of 35.5 suggests that the current outperformance is not at an extreme high compared to its historical range.
*   A relative divergence of 35.5 indicates that the current divergence is closer to the lower end of its historical range (Min: -37.8, Max: 98.9). This suggests there could be potential for further outperformance based on past performance patterns.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 68.0% | 77.6% | 40.0% | -0.1 | 43.6   |
| 2016-2018  | 64.0% | 72.2% | 49.0% | -0.0 | 57.2   |
| 2017-2019  | 54.0% | 72.2% | 31.0% | 0.2  | 70.6   |
| 2018-2020  | -6.0% | 80.4% | -29.0% | 0.3  | 97.8   |
| 2019-2021  | 29.0% | 80.4% | -18.0% | 0.6  | 128.8  |
| 2020-2022  | -23.0% | 80.4% | -22.0% | 1.2  | 95.1   |
| 2021-2023  | -17.0% | 77.5% | -18.0% | 1.7  | 120.9  |
| 2022-2024  | 36.0% | 77.5% | 15.0% | 1.7  | 187.1  |
| 2023-2025  | 76.0% | 72.7% | 8.0%  | 0.8  | 207.1  |

*   **CAGR (Compound Annual Growth Rate):**  Demonstrates periods of significant growth (e.g., 2015-2017, 2016-2018, 2023-2025) and periods of negative growth (2018-2020, 2020-2022, 2021-2023).
*   **MDD (Maximum Drawdown):** High MDD values indicate substantial risk and volatility. The consistent MDD around 70-80% suggests significant potential losses during downturns.
*   **Alpha:**  Represents excess return compared to the benchmark.  Negative alpha values in recent periods (2018-2023) indicate underperformance relative to the market, while positive alpha in earlier periods (2015-2019, 2022-2024) indicates outperformance.
*   **Beta:** Shows the stock's volatility relative to the market.  Beta values ranging from -0.1 to 1.7 indicate ISRG's volatility can vary widely.  A beta greater than 1 (especially in later years) suggests that the stock is more volatile than the market.
*   **Cap (B):** Indicates the market capitalization of ISRG in billions of dollars. The increasing market capitalization indicates significant growth over the period, despite volatility in returns.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 577.81
*   **Previous Close:** 577.15
*   **Change:** 0.11
*   **5-day SMA:** 576.92
*   **20-day SMA:** 565.53
*   **60-day SMA:** 531.81

**Analysis:**

*   The stock is currently trading slightly above its previous close, indicating a minor upward movement.
*   The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA. This indicates a short-term uptrend, with the stock price recently trending higher than its longer-term averages.
*   The change is small. The fact the change is small indicates stable short-term price activity, meaning no sharp reboud or decline, but the general uptrend pattern is clear.

**3) Indicator Analysis**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 51.47
*   **PPO (Percentage Price Oscillator):** 0.0937
*   **Hybrid Signal:** Cash 0%, Buy 90% of cash (2 shares - Safe - MRI: 0.80)
*   **Recent Divergence Change:** 8.0 (+) (Short-term increase)
*   **Expected Return:** 23.9%

**Analysis:**

*   The high MRI score (1.0) suggests a favorable investment environment.
*   An RSI of 51.47 is neutral, indicating neither overbought nor oversold conditions.
*   A positive PPO (0.0937) indicates a short-term uptrend is in place.
*   The Hybrid Signal indicates a strong buy recommendation, suggesting to invest almost all available cash, further reinforcing the positive outlook, however note the MRI of 0.80 means this decision is "Medium Risk".
*   The increase in relative divergence and the expected return of 23.9% suggest potential for continued outperformance.

**4) Recent News & Significant Events**

*   **Intuitive Surgical, Inc. $ISRG Shares Sold by Beacon Investment Advisory Services Inc.** This indicates some institutional selling pressure, which might be a short-term headwind.
*   **Intuitive Surgical Stock Surged 30%, Here's Why:** This indicates a significant positive movement, likely driven by specific events or positive sentiment.
*   **Intuitive Surgical (ISRG): Revisiting Valuation After a 25% Three-Month Share Price Surge:** This news suggests that the market is reassessing the stock's value after recent strong performance.
*   **Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025:** General news related to the stock, indicating investor interest.
*   **Is ISRG's 20% Procedure Growth the New Normal or a Peak?:** Focuses on the sustainability of the company's growth rate in procedures performed using its surgical systems.
*   **What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT):**  Suggests ISRG is a top pick in healthcare but offers a more conservative alternative.

**Analysis:**

The recent news indicates a mixed sentiment. The 30% surge and revisiting valuation suggest positive momentum, while the Beacon Investment Advisory Services Inc. selling shares implies some level of profit-taking or reallocation of funds. The sustainability of procedure growth and comparison with Medtronic suggests careful consideration of growth potential and risk.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (2.06 on a 1-5 scale)
*   **Target Price:** Average 599.60, High 700.00, Low 378.00
*   **Recent Rating Changes:** Not provided in this report.

**Analysis:**

The analyst consensus of "Buy" indicates a positive outlook. The average target price of $599.60 suggests potential upside from the current price. The range of target prices indicates varying degrees of optimism among analysts.
**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-10-22 | 1.98  | 2.51 B$   |
| 2025-07-23 | 1.84  | 2.44 B$   |
| 2025-04-23 | 1.95  | 2.25 B$   |
| 2024-10-18 | 1.59  | 2.04 B$   |
| 2025-10-22 | 1.59  | 2.04 B$   |

**Analysis:**

*Note the date 2025-10-22 is duplicated.*

Earnings per share (EPS) and revenue show a generally increasing trend from 2024 to 2025, indicating financial growth. The EPS fluctuated between 1.59 and 1.98 B$, but the overall revenue grew consistently.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $2.51B  | 66.36%        |
| 2025-06-30 | $2.44B  | 66.31%        |
| 2025-03-31 | $2.25B  | 64.69%        |
| 2024-12-31 | $2.41B  | 68.04%        |
| 2024-09-30 | $2.04B  | 67.41%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-09-30 | $16.93B   | 4.16%  |
| 2025-06-30 | $17.85B   | 3.69%  |
| 2025-03-31 | $17.11B   | 4.08%  |
| 2024-12-31 | $16.43B   | 4.17%  |
| 2024-09-30 | $15.58B   | 3.63%  |

**Analysis:**

*   **Revenue:**  Shows steady growth, indicating increasing demand for Intuitive Surgical's products and services.
*   **Profit Margin:** Consistently high, suggesting strong operational efficiency and pricing power.
*   **Equity:**  Increasing equity indicates financial stability and growth.
*   **ROE (Return on Equity):**  Fluctuates but remains relatively stable, indicating consistent profitability relative to equity.

**7) Comprehensive Analysis:**

Intuitive Surgical (ISRG) demonstrates strong financial performance, outperforming the S&P 500, however it experienced recent periods of underperformance based on the Alpha calculation. The stock shows an uptrend based on moving averages, a positive market risk indicator, and a buy recommendation from the Hybrid Signal, however be mindful this is classified as Medium Risk. Recent news highlights a mixed sentiment, with institutional selling and discussions on valuation and procedure growth sustainability. Analyst consensus remains positive, with a "Buy" rating and potential upside based on target prices. The company shows consistent revenue growth, high profit margins, and a stable return on equity.

**Overall, the analysis suggests that Intuitive Surgical is a fundamentally strong company with continued growth potential. The investor should consider both the positive momentum and potential risks.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.